Let’s Advance Oncology Research Together

Ergomed Clinical Research is actively expanding our network of U.S. oncology sites to support a growing portfolio of early-phase and first-in-human oncology trials. As a CRO with a long-standing commitment to complex oncology studies, we understand the operational and scientific demands sites face—and we work to ensure our site partners are equipped, supported, and set up for success.

Your Site. Our Trials. One Purpose.

Whether your site specializes in solid tumors, hematologic malignancies, or rare cancers, registering with Ergomed connects you with global biopharma sponsors and opportunities to participate in trials at the forefront of oncology innovation. We prioritize investigator engagement, operational transparency, and tailored support that allows each site to focus on delivering quality care and reliable results.

By registering, your site will be considered for upcoming clinical trial opportunities that align with your expertise, infrastructure, and therapeutic focus. We welcome both established research sites and those new to early-phase oncology studies.

    • Access to new study opportunities in oncology, including early-phase and rare cancer trials

    • Streamlined site engagement with a dedicated point of contact

    • Global sponsor collaborations through Ergomed’s extensive biotech and pharma network

    • Site-first approach focused on partnership, performance, and patient access

Register Your Site for Upcoming Oncology Trials

Please complete the form below to tell us more about your site. Once submitted, our team will be in touch and keep you informed about relevant upcoming trials.

Empowered Sites, Ergo, Efficient Trial Delivery

Contact Us

Our Complementary Services

See how Ergomed can support your clinical trial.

More Ergomed Services

Find out how Ergomed supports your clinical trial objectives.

Discover Our Latest Insights

Access Ergomed's resources for the latest in clinical trial trends and innovations.